CIHR Scientific Director appointed Chair of Global Research Collaboration for Infectious Disease Preparedness

The Global Research Collaboration for Infectious Disease Preparedness (GloPID-R) today announced the appointment of Dr. Charu Kaushic as its new Chair for a two-year term. Dr. Kaushic is Scientific Director of CIHR’s Institute of Infection and Immunity and was previously one of the Co-Chairs of GloPID-R.

Established in 2013, GloPID-R brings together research funding organizations on a global scale to facilitate effective and rapid research in response to a significant outbreak of an infectious disease with epidemic and pandemic potential.

GloPID-R is composed of 29 members, representing national research funding organizations in countries around the world, and 3 partners, including the World Health Organization. CIHR’s Institute of Infection and Immunity is a founding member of GloPID-R.

“I am honoured to serve as the new Chair of GloPID-R,” said Dr. Kaushic.”The role of this unique global network in coordinating and funding research in the area of pandemic preparedness and response has never been more vital than in the context of the ongoing COVID-19 crisis.

GloPID-R is led by a Board of Chairs who are elected from among the members and who work in close cooperation with the Secretariat, a Scientific Advisor, and committees composed of network members.

Dr. Kaushic will work with the Co-Chairs to pursue, strengthen and expand GloPID-R’s goals to support the development of research preparedness activities, to reinforce rapid response capacities, and to coordinate the membership to facilitate the rapid and aligned funding of research in a public health emergency.

GloPID-R has played a leadership role in the global research response to the COVID-19 pandemic. In February 2020, at the beginning of the pandemic, GloPID-R, in collaboration with WHO, hosted the Global Research and Innovation Forum: Towards a Research Roadmap for the 2019 Novel Coronavirus [ PDF (421 KB) - external link ], which set the global research roadmap for COVID-19. They have also facilitated an unprecedented level of coordination and communication among network members convening, for example, a series of virtual research synergy meetings designed to share the latest scientific information and identify knowledge gaps and opportunities for collaboration.

“In the last ten months, we have seen that global cooperation is critical to moving the science and research agenda forward in a coordinated manner so we can achieve our common goal to end this pandemic,” added Dr. Kaushic. “I look forward to working closely with our 32 members and partners to realize the vision of GloPID-R.”

“I am delighted that Charu will assume this global leadership role,” said Dr. Michael Strong, President of CIHR. “Collaboration has been an essential component of our research response to COVID-19 in Canada and internationally. As Chair of GloPID-R, Charu will be a powerful advocate for science and research in public health emergencies and will help us align our priorities so that we support research that responds to the needs of Canadians while contributing to the global community.”

Date modified: